HOME > TOP STORIES
TOP STORIES
-
ACADEMIA Overseas Meta-Analyses Find Increased Risk of CKD in Patients Who Use PPIs; Japanese Society of Nephrology Plans Study of Japanese Patients
February 2, 2018
-
BUSINESS Astellas Taps EVP Yasukawa as Next CEO
February 1, 2018
-
REGULATORY Drug Makers Looking to Adopt Continuous Manufacturing, Anticipating 30-40% Lower Production Costs: PMDA Official
January 31, 2018
-
ORGANIZATION Japan Could Miss Out on Wave 1 of Drug Development, Re-Do and Do Right on PMP: PhRMA
January 30, 2018
-
BUSINESS Sanofi to Launch Antibody Drug Dupilumab for Atopic Dermatitis this Spring, Sets Up Special Marketing Force for Potential Blockbuster
January 30, 2018
-
BUSINESS New PMP Scheme Will Cause “Pause” before PIII Go/No-Go Decision: Pfizer Japan Head
January 29, 2018
-
REGULATORY IPRP to Hold First Meeting in June in Japan, May Take up Harmonization of Regulations on Regenerative Medicine Products
January 26, 2018
-
REGULATORY MHLW to Launch New Project to Strengthen Generic Drug Use in Around 10 “Priority Prefectures” Aiming at 80% Volume Share Target
January 25, 2018
-
BUSINESS Biogen Japan to Kick Off PIII Study for Stroke Drug by Year-End
January 24, 2018
-
REGULATORY Shionogi’s Sakigake-Designated Flu Med Up for MHLW Panel Review on Feb. 2, Early Listing Possible?
January 23, 2018
-
REGULATORY MHLW OKs Dupixent, Tecentriq, Lynparza, and More
January 22, 2018
-
BUSINESS Industry Expresses Disappointment about “Expansion” of Essential Drugs; Some Looking to Real Expansion in FY2020
January 19, 2018
-
BUSINESS Another Drug Lag “Will” Arise, Says Mitsubishi Tanabe President after JPMA Chief’s Denial
January 19, 2018
-
REGULATORY Huge Seller Price Slash to Hit Nexium/Takecab; Rituxan, 8 Other Brands to Face Market Expansion Re-Pricing
January 18, 2018
-
REGULATORY Chuikyo OKs Special Re-Pricing for FY2018 Drug Price Revision, Here’s the List of Products
January 17, 2018
-
REGULATORY MHLW Health Policy Chief Wants Pricing Reform to Prod Drug Makers’ Overseas Expansions
January 17, 2018
-
BUSINESS Japan’s 1st Rituxan Biosimilar to Hit Shelves as Scheduled despite Patent Suit Filed
January 16, 2018
-
ORGANIZATION Exclude 50 Yen or Lower Price Generics from “Off-Year” Re-Pricing: JGA Chief
January 15, 2018
-
REGULATORY Streamlining Regulations of Pharmaceutical Affairs to Be “a Top Priority” in 2018: MHLW Pharma Bureau Chief
January 12, 2018
-
BUSINESS Will Symbicort and Adoair Face Generic Entries This Year? Trade Group Has Seen High Hurdle for Inhaler Drugs
January 11, 2018
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
